Titan Biotech
928.20
-45.35(-4.66%)
Market Cap₹804.50 Cr
PE Ratio36.57
IndustryChemicals
Company Performance:
1D-4.66%
1M+98.82%
6M+92.65%
1Y+30.25%
5Y+581.25%
View Company Insightsright
Latest news about Titan Biotech
Titan Biotech Reports 8% Revenue Growth and Board Changes in Q1 FY2026 Aug 13, 2025
Titan Biotech Limited reported a 7.8% increase in standalone revenue to Rs. 46.50 crore and an 8.1% rise in net profit to Rs. 6.16 crore for Q1 FY2026. The company appointed Mr. Debendra Kumar Sabat as Additional Independent Director and re-appointed Mr. Naresh Kumar Singla and Mr. Suresh Chand Singla as Managing Directors for five-year terms. A final dividend of Rs. 2.00 per share was recommended for FY2025. The 33rd Annual General Meeting is scheduled for September 26, 2025, with e-voting facilities available for shareholders.